Comparing efficacy of Erenumab (CGRP receptor mAb) versus galacanezumab or fremanezumab CGRP ligand antibody in migraine patients
Latest Information Update: 14 Jul 2020
At a glance
- Drugs Erenumab (Primary) ; Fremanezumab (Primary) ; Galcanezumab (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 14 Jul 2020 New trial record
- 20 Jun 2020 Results presented at the 62nd Annual Scientific Meeting of the American Headache Society